Pharmacotherapy versus T lymphocytes for CMV

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations


In this issue of Blood, Blyth et al report a phase 2 study in 50 allogeneic hematopoietic stem cell transplant (HSCT) recipients who received donorderived cytomegalovirus (CMV) - specific cytotoxic T cells (CTLs) and compare outcomes with a group of concomitant controls who were transplanted at the trial centers but who did not receive CTLs.

Original languageEnglish (US)
Pages (from-to)3544-3545
Number of pages2
Issue number18
StatePublished - May 2 2013

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Pharmacotherapy versus T lymphocytes for CMV'. Together they form a unique fingerprint.

Cite this